"Part of the HonorHealth Virginia G. Piper Cancer Care Network, the Glendale cancer center has expert, compassionate physicians with special training in diagnosing and treating cancer and blood disorders."

During the past decade, Virginia G Piper Cancer Care-Glendale conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Virginia G Piper Cancer Care-Glendale" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "United States Department of Defense" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Virginia G Piper Cancer Care-Glendale" are "Estrogen Receptor Negative" (2 trials), "Progesterone Receptor Negative" (2 trials), "Stage IIIA Breast Cancer" (2 trials), "Breast Adenocarcinoma" (1 trials) and "Breast Carcinoma" (1 trials). Many other conditions were trialed in "Virginia G Piper Cancer Care-Glendale" in a lesser frequency.

Most popular intervention types in "Virginia G Piper Cancer Care-Glendale" are "Drug" (2 trials), "Other" (2 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aspirin" (1 trials), "Axillary Lymph Node Dissection (ALND)" (1 trials), "Axillary Radiation Therapy" (1 trials), "Biospecimen Collection" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Virginia G Piper Cancer Care-Glendale" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Virginia G Piper Cancer Care-Glendale". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Virginia G Piper Cancer Care-Glendale, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Virginia G Piper Cancer Care-Glendale, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".